NCERT Class 12 Biology Ch 7 Human Health & Disease Solutions PDF

Concept used. Infectious diseases are illnesses caused by pathogens (disease-causing microorganisms such as bacteria, viruses, protozoans, fungi and helminths) that spread from an infected host to a healthy one. Public health measures are organised actions, taken at the level of the community by the government, by health agencies and by individuals, to prevent the entry, the multiplication and the spread of these pathogens. They break the chain of transmission at one or more of three points: the source, the route and the susceptible host.

1. Personal hygiene. Keeping the body clean, taking a regular bath, washing hands with soap before eating and after using the toilet, brushing teeth, trimming nails, and wearing clean clothes. Personal hygiene checks the entry of pathogens of typhoid, amoebiasis, ascariasis, ringworm and many other infections that travel by the faecal-oral route or by skin contact.
2. Public sanitation. Proper disposal of garbage and excreta, periodic cleaning and disinfection of water reservoirs and tanks, swimming pools and cisterns, and the use of clean and covered drains. These measures cut off the route of water-borne and food-borne diseases such as cholera, typhoid, amoebiasis and ascariasis.
3. Safe and clean drinking water. Drinking only boiled, filtered or chlorinated water; protecting tube-wells and hand-pumps from contamination; and avoiding open street beverages prevents water-borne diseases like typhoid, cholera, amoebiasis and hepatitis A.
4. Control of vectors and their breeding grounds. Eradication of mosquito-breeding sources by draining stagnant water from coolers, tyres, pots and gutters, spraying insecticides (DDT in older programmes, today pyrethroids), introducing larvivorous fish such as Gambusia into ponds, and using mosquito nets and repellents controls malaria, dengue, chikungunya, filariasis. Similarly, controlling rats, flies and cockroaches checks plague and many enteric infections.
5. Vaccination and immunisation. Routine immunisation of infants and children against polio, diphtheria, tetanus, pertussis, measles, mumps, hepatitis-B and tuberculosis builds active immunity in the population and gives herd immunity, which protects even the un-immunised.
6. Health education. Awareness drives through school programmes, posters, electronic and print media on safe sex, safe food, hand-washing, oral rehydration, breast-feeding, and the dangers of self-medication empower people to protect themselves.
7. Early diagnosis and treatment. Screening, easy access to government dispensaries, free essential drugs (DOTS for tuberculosis, ART for HIV), and the timely isolation of cases prevent secondary transmission.

Personal hygiene, public sanitation, safe drinking water, vector control, vaccination, health education and prompt diagnosis-treatment together form the core public-health shield against infectious diseases.

Concept used. The control of an infectious disease rests on three pillars: (i) knowing the pathogen that causes it, (ii) knowing the life cycle and mode of transmission of that pathogen, and (iii) designing tools (drugs, vaccines, vector controls, diagnostic tests) that strike specifically at the pathogen or its weak link. Each of these pillars rests on biology, that is, on what microbiology, immunology, biochemistry, molecular biology and biotechnology have discovered.

1. Discovery and identification of pathogens. Microbiology has shown that infectious diseases are caused by specific organisms: malaria by Plasmodium, typhoid by Salmonella typhi, cholera by Vibrio cholerae, TB by Mycobacterium tuberculosis, AIDS by HIV, amoebiasis by Entamoeba histolytica, ringworm by Microsporum, Trichophyton, Epidermophyton. Without this knowledge no targeted control is possible.
2. Understanding life cycles and transmission. Parasitology and ecology have mapped the life cycles, like the Plasmodium cycle between female Anopheles and humans, and the Ascaris faecal-oral cycle. This knowledge tells us where to break the cycle (e.g. kill mosquito larvae, treat drinking water).
3. Development of drugs and antibiotics. Pharmacology and biotechnology have given us specific antimicrobials: chloroquine and artemisinin for malaria, penicillin and cephalosporins for bacteria, fluconazole for fungal infections, antiretrovirals (ART) for HIV. Each kills the pathogen with minimum damage to the host.
4. Vaccines and immunisation. Immunology has revealed the antigen-antibody system, allowing scientists to design vaccines (live attenuated, killed, sub-unit, recombinant DNA vaccines like Hepatitis B, mRNA vaccines like COVID-19). Vaccines have eradicated smallpox and have brought polio, measles and diphtheria under tight control.
5. Diagnostic technology. Molecular biology has given rapid, sensitive tests: ELISA for HIV and dengue, Widal for typhoid, PCR for tuberculosis and COVID-19, microscopy for malaria. Early diagnosis means early treatment and less secondary spread.
6. Vector and reservoir control. Entomology and ecology have identified vectors and their breeding habits, leading to integrated vector management: insecticides, larvivorous fish, biocontrol, and habitat modification.
7. Genetic engineering and biotechnology. Recombinant vaccines (Hep B), monoclonal antibodies (for cancer, COVID), gene therapy and DNA vaccines are direct fruits of modern biology.

Biology, through microbiology, immunology, pharmacology, biotechnology and ecology, has given us the pathogens' identity, their life cycles, the drugs to kill them, the vaccines to prevent them, the tests to detect them and the controls to interrupt their transmission. That is how we control infectious diseases today.

Concept used. Transmission is the route by which a pathogen passes from an infected source (a sick person, a carrier or a contaminated reservoir) to a healthy susceptible host. The four diseases asked here run on four distinct routes: faecal-oral (water/food), vector-borne (mosquito bite), faecal-oral (soil/water contaminated with eggs), and respiratory droplet.

1. (a) Amoebiasis (amoebic dysentery). Caused by the protozoan Entamoeba histolytica. The pathogen lives as a cyst in the large intestine of infected people. Cysts are released in their faeces. When faeces contaminate food or drinking water, or when houseflies (mechanical vectors) carry the cysts onto exposed food, a healthy person who eats or drinks the contaminated material picks up the infection. Hence faecal-oral transmission through contaminated food and water; flies act as mechanical carriers.
2. (b) Malaria. Caused by Plasmodium species (P. vivax, P. malariae, P. ovale and the deadliest P. falciparum). It needs two hosts: a female Anopheles mosquito and a human. When an infected female Anopheles bites a healthy human, it injects sporozoites (the infective form) into the blood; they enter liver cells, multiply, then infect RBCs. When a fresh Anopheles bites the patient, it picks up gametocytes, which fuse and develop in the mosquito gut. Hence vector transmission through the bite of an infected female Anopheles mosquito.
3. (c) Ascariasis. Caused by the intestinal round-worm Ascaris lumbricoides. Adult worms in the intestine of an infected person release thousands of eggs that pass out in the faeces and pollute soil, water, plants and vegetables. A healthy person who eats raw or poorly washed vegetables, drinks contaminated water, or puts dirty hands in the mouth swallows the embryonated eggs and develops the disease. Hence faecal-oral transmission via soil, water and vegetables contaminated with eggs.
4. (d) Pneumonia. Caused chiefly by the bacteria Streptococcus pneumoniae and Haemophilus influenzae. The pathogen lodges in the alveoli of the infected person's lungs and is released in the tiny droplets that come out when the patient coughs, sneezes or talks. A healthy person inhales these droplets, or comes into contact with the patient's utensils, glass or used tissue, and picks up the bacteria. Hence droplet (air-borne) transmission through coughing/sneezing and through shared utensils.

Amoebiasis and ascariasis spread by the faecal-oral route through contaminated food and water; malaria spreads by the bite of an infected female Anopheles mosquito; pneumonia spreads by inhaled respiratory droplets from a sick person.

Concept used. Water-borne diseases are diseases whose pathogens travel from sick to healthy people in contaminated drinking water. Typical examples are typhoid, cholera, amoebiasis, hepatitis A, polio, ascariasis and several diarrhoeal illnesses. Prevention works at two ends: (i) stop the pathogen from getting into the water, and (ii) purify the water before drinking.

1. Provide clean, treated drinking water. Use municipal treated water; if unsure, boil drinking water for at least 10minutes to kill bacteria, viruses, protozoan cysts and worm eggs. Alternatively, treat water with chlorine tablets, ultraviolet (UV) light, or pass it through a tested ceramic/RO filter.
2. Protect water sources from contamination. Keep wells, tube-wells and hand-pumps covered. Place pit latrines and soak-pits at least 15m away from any drinking-water source. Do not allow sewage, animal waste or industrial effluent to drain into ponds, rivers and reservoirs used for drinking.
3. Proper disposal of faeces and sewage. Use proper toilets connected to septic tanks or a covered drainage system. Open defecation contaminates soil and rainwater run-off, which then enters surface water bodies.
4. Personal hygiene. Wash hands thoroughly with soap and clean water before preparing or eating food and after using the toilet. Avoid drinking from open glasses at street stalls; avoid ice made from untreated water.
5. Food and kitchen hygiene. Wash fruits and vegetables with treated water; do not eat cut/peeled fruits sold on the roadside; cover cooked food to keep flies off; do not store drinking water in open vessels.
6. Public sanitation drives. Periodic cleaning and chlorination of community water tanks; control of houseflies (which carry pathogens from faeces to food); regular inspection of water-pipes for leaks (sewage seeps into them through fractures and creates outbreaks).
7. Vaccination and prompt treatment. Vaccines for typhoid, cholera and hepatitis A protect specifically against water-borne pathogens. Patients of cholera or dysentery should be treated quickly with oral rehydration solution (ORS) and appropriate antibiotics to stop further shedding.

Drink only treated/boiled/filtered water; protect drinking sources from sewage; use covered toilets; wash hands with soap; keep food and kitchen clean; chlorinate community tanks; and take available vaccines for typhoid, cholera and hepatitis A.

Concept used. A DNA vaccine (also called a third-generation vaccine) is a small circular piece of DNA (a plasmid) carrying the gene that codes for one or more antigenic proteins of the pathogen we want to vaccinate against. When the plasmid is injected into a host, the host's own cells transcribe and translate the gene, the antigen protein appears on the cell surface, and the host's immune system makes antibodies and memory cells against it. Hence a suitable gene is the specific piece of pathogen DNA that, when expressed in the host, produces a protein that triggers a strong, lasting, protective immune response without causing disease.

1. It must code for an antigenic protein of the pathogen. The gene must encode a protein the immune system recognises as `non-self', so that B-cells and T-cells respond. Surface proteins, capsid proteins or envelope glycoproteins are usual choices (for example the spike-protein gene for SARS-CoV-2, the HBsAg gene for Hepatitis B virus, the circumsporozoite-protein gene for Plasmodium).
2. The protein must elicit protective immunity. Some antigens make antibodies that bind but do not block the pathogen; the chosen gene must give a neutralising response, i.e. the antibodies should actually stop infection or kill the pathogen.
3. It must be safe. The gene must not code for any toxin or any protein that lets the pathogen multiply inside the host. It is only the antigen, never the whole pathogen.
4. It must be conserved across strains. The gene's product should not change easily between strains and seasons, otherwise the vaccine quickly becomes useless (a problem with the influenza virus's surface antigens).
5. It must be efficiently expressed in human cells. The gene is placed under a strong human-cell promoter (typically the CMV promoter) so that the host cell makes plenty of antigen. The gene's sequence is sometimes codon- optimised for human ribosomes.
6. It must be small enough to clone into a plasmid. Practical plasmids carry roughly ≤ 10 kb of insert; a good vaccine gene is usually 1–3 kb.

A `suitable gene' for a DNA vaccine is a small, conserved, non-toxic piece of pathogen DNA that codes for an antigenic surface protein, is efficiently expressed in human cells, and elicits a strong, lasting and protective (neutralising) immune response.

Concept used. The lymphoid system is a network of organs and tissues where the cells of the immune system (lymphocytes: B and T cells) are produced, mature and act. Primary lymphoid organs are the sites where immature lymphocytes are produced and undergo maturation into immuno- competent B and T cells (i.e. cells able to recognise self from non-self). Secondary lymphoid organs are the sites where the matured lymphocytes meet antigens, get activated, multiply clonally and mount the actual immune response.

1. Primary lymphoid organs. (i) Bone marrow is the main site where all blood cells, including lymphocytes, are produced. B-lymphocytes mature here in mammals. (ii) Thymus is a lobed organ near the heart, beneath the breast-bone. It is large in babies but shrinks with age (involution). T-lymphocytes are formed in the bone marrow and then migrate to the thymus, where they mature. Both bone marrow and thymus also provide the microenvironment for self-tolerance: lymphocytes that react against the body's own tissues are eliminated here.
2. Secondary lymphoid organs. (i) Spleen: a bean-shaped organ in the upper left abdomen; filters blood-borne microbes and stores lymphocytes. (ii) Lymph nodes: bean-shaped, scattered through the body along lymphatic vessels; trap micro-organisms and antigens that enter the lymph and tissue fluid. (iii) Tonsils: at the back of the throat; guard against pathogens entering through the mouth and nose. (iv) Peyer's patches of the small intestine. (v) Appendix. (vi) Mucosa-associated lymphoid tissue (MALT): located within the lining of the respiratory, digestive and urogenital tracts; about 50% of the body's lymphoid tissue lies in the MALT.

Primary lymphoid organs: bone marrow and thymus. Secondary lymphoid organs: spleen, lymph nodes, tonsils, Peyer's patches, appendix and MALT.

Concept used. The chapter introduces several biomedical acronyms that recur in immunology and public health. Memorising both the full form and a one-line meaning is enough for board and NEET marks.

1. (a) MALT = Mucosa-Associated Lymphoid Tissue. The diffuse lymphoid tissue embedded in the mucous lining of the respiratory, digestive and urogenital tracts. It is a secondary lymphoid tissue and constitutes about 50% of the body's total lymphoid tissue.
2. (b) CMI = Cell-Mediated Immunity. The arm of acquired immunity executed by activated T-lymphocytes (rather than circulating antibodies). It is responsible for defence against intracellular pathogens (viruses, Mycobacterium) and for the rejection of grafts.
3. (c) AIDS = Acquired Immuno-Deficiency Syndrome. A deadly disease caused by HIV, marked by a progressive loss of helper T-cells, repeated opportunistic infections, weight loss, swollen lymph glands and ultimately death if untreated.
4. (d) NACO = National AIDS Control Organisation. A body of the Ministry of Health and Family Welfare, Government of India, set up in 1992 to oversee HIV/AIDS prevention, diagnosis, treatment (ART) and awareness in India.
5. (e) HIV = Human Immuno-deficiency Virus. The retrovirus that causes AIDS. It is an RNA virus with the enzyme reverse transcriptase; it infects helper T-cells (CD4⁺) and macrophages of the human immune system.

(a) MALT = Mucosa-Associated Lymphoid Tissue;   (b) CMI = Cell-Mediated Immunity;   (c) AIDS = Acquired Immuno-Deficiency Syndrome;   (d) NACO = National AIDS Control Organisation;   (e) HIV = Human Immuno-deficiency Virus.

Concept used. Immunity is the overall ability of the body to fight disease-causing organisms. It has two broad divisions based on how the protection is acquired: innate (present at birth) vs. acquired (developed during life). The acquired arm further splits into active (the body itself makes antibodies) vs. passive (ready-made antibodies are received from outside).

1. (a) Innate vs. Acquired immunity.
   tabularp0.42 p0.50 Innate (non-specific) immunity & Acquired (specific) immunity
   Present from birth; inherited from parents. & Develops over the lifetime in response to specific pathogens.
   Non-specific: acts on every type of microbe. & Specific: responds to a particular pathogen.
   Acts immediately; no time-lag. & Slower (5–14 days for primary response).
   No immunological memory; same response every time. & Memory cells remember the pathogen; faster, stronger secondary response on re-exposure.
   Four barriers: physical (skin, mucous), physiological (HCl in stomach, lysozyme in tears/saliva), cellular (PMN-leucocytes, monocytes, NK cells, macrophages), cytokine (interferons). & Two arms: humoral (B-cells make antibodies in blood) and cell-mediated (T-cells attack infected cells/grafts).
   Example: skin keeps microbes out; stomach acid kills swallowed bacteria; lysozyme in tears destroys bacteria in the eye. & Example: antibodies produced after measles infection or after the MMR vaccine; T-cell killing of virus-infected cells; rejection of an unmatched organ graft.
   tabular
2. (b) Active vs. Passive immunity.
   tabularp0.42 p0.50 Active immunity & Passive immunity
   The host's own immune system makes antibodies on exposure to the antigen. & Ready-made antibodies (antiserum) are received from outside.
   Slow to develop (days to weeks) but long-lasting; memory cells form. & Acts at once but is short-lived (a few weeks); no memory.
   Examples of natural active immunity: recovery from measles, mumps, chicken-pox. Examples of artificial active immunity: vaccination with polio, MMR, hepatitis-B, COVID-19 vaccine. & Examples of natural passive immunity: IgG antibodies transferred from mother to foetus through the placenta; IgA antibodies in colostrum to a newborn. Examples of artificial passive immunity: anti-tetanus serum (ATS), anti-snake-venom serum, monoclonal antibodies for COVID-19.
   tabular

(a) Innate: inborn, non-specific, immediate, no memory (skin, stomach HCl, lysozyme, phagocytes). Acquired: develops during life, pathogen-specific, slower, has memory (antibodies after vaccination/recovery, T-cell graft rejection). (b) Active: body itself makes antibodies, slow, long-lasting (vaccination, natural recovery). Passive: ready-made antibodies given, quick, short-lived (anti-tetanus serum, mother's milk antibodies).

Concept used. An antibody (immunoglobulin, Ig) is a Y-shaped protein produced by B-lymphocytes in response to a specific antigen. Each antibody molecule has four polypeptide chains: two identical light (L) chains and two identical heavy (H) chains. Because of this H₂L₂ composition, the molecule is symbolically written as H₂L₂. The two arms of the Y end in identical antigen-binding sites, which recognise and bind the specific antigen. The chains are held together by disulphide (-S-S-) bonds. Each chain has a variable (V) region (the antigen-binding end) and a constant (C) region (the stem). The five major immunoglobulin classes are IgA, IgD, IgE, IgG and IgM, distinguished by their heavy-chain constant regions.

1. Identify the four chains. Two long heavy chains run as the trunk and inner arm of the Y. Two short light chains sit on the outside, one alongside each heavy arm.
2. Mark the antigen-binding sites. The two upper tips of the Y, where one light and one heavy chain meet, are the identical antigen-binding sites. Each binds one antigen molecule, so a single antibody can bind two antigens.
3. Mark the disulphide bonds. Several -S-S- bridges hold the heavy chains to each other (in the hinge region) and each light chain to its heavy chain. They keep the four-chain assembly together.
4. Mark the variable (V) and constant (C) regions. The V region (the upper part of each arm) is highly variable across antibodies and gives them their specificity. The C region (the lower part of the stem) is conserved within each Ig class and decides effector function. Label the N-terminus and C-terminus accordingly.
5. State the formula. Because there are two H and two L chains, the formula is H₂L₂.

An antibody is a Y-shaped protein with H₂L₂ four-chain composition: 2 heavy + 2 light chains linked by -S-S- bonds, ending in two identical antigen-binding sites at the variable (V) tips of the Y, with the constant (C) stem deciding the immunoglobulin class (IgA, IgD, IgE, IgG, IgM).

Concept used. HIV is a retrovirus that lives inside cells of the human immune system and inside body fluids (blood, semen, vaginal secretions, breast-milk). It is fragile outside the body and cannot spread through air, food, water, casual contact, mosquitoes, sharing toilets or insect bites. It can only spread when one of these contaminated body fluids of an infected person enters the bloodstream of a healthy person. Hence there are four main routes.

1. Sexual contact. Unprotected sexual intercourse (vaginal, anal or oral) with an HIV-infected person is the commonest route. Semen and vaginal secretions of the infected partner carry the virus; small abrasions in the mucosa of the healthy partner let it enter the blood.
2. Blood and blood products. Transfusion of infected blood or blood products (plasma, platelets, clotting factors in haemophiliacs) was a major route before donor screening became universal. Today, mandatory ELISA screening has largely closed this route in regulated blood banks.
3. Sharing of infected needles or syringes. Common among intravenous drug abusers who share needles; also a risk during unsafe medical injections, ear-piercing, tattooing and acupuncture with poorly sterilised equipment.
4. Mother-to-child (vertical) transmission. An HIV-positive mother can transmit the virus to her child: (i) across the placenta during pregnancy, (ii) through blood contact during childbirth, or (iii) through breast-milk during nursing.

HIV spreads through four established routes only: (i) unprotected sexual contact with an infected partner; (ii) transfusion of infected blood/blood products; (iii) sharing of infected needles, syringes or sharp instruments; (iv) from an infected mother to her child during pregnancy, delivery or breast-feeding.

Concept used. The AIDS virus (HIV) is a retrovirus: its genome is single-stranded RNA enclosed in a protein coat surrounded by a lipid envelope studded with glycoprotein spikes. Inside its capsid it also carries the enzyme reverse transcriptase. The virus specifically targets the helper T-lymphocytes (T_H cells, also called CD4⁺ T-cells) and macrophages of the human immune system. Repeated cycles of infection, replication and killing of T_H cells progressively destroy this central co-ordinator of the immune response, leaving the patient unable to defend against secondary infections. That progressive loss is the immunodeficiency of AIDS.

1. Entry. After transmission, HIV enters macrophages. Its envelope glycoprotein (gp120) binds specifically to the CD4 receptor on macrophages and helper T-cells, and the virus is taken into the cell.
2. Reverse transcription. Inside the cell, the viral enzyme reverse transcriptase copies the single- stranded RNA genome into a double-stranded DNA. This step gives the retrovirus its name (the reverse of the usual DNA -> RNA flow).
3. Integration. The newly synthesised viral DNA enters the nucleus of the host cell and integrates into the host chromosome (catalysed by viral integrase). The virus now lives as a permanent passenger of the cell.
4. Replication and budding. The infected cell is directed by the integrated viral DNA to produce new viral RNA genomes and viral proteins. These assemble at the cell membrane and bud off as new virions, which infect more macrophages and helper T-cells.
5. Destruction of helper T-cells. Each round of replication destroys the infected T_H cell. Because T_H cells are the central co-ordinators of the immune response (they activate B-cells for antibody production and activate cytotoxic T-cells), a progressive fall in their number cripples both humoral and cell-mediated immunity. Normal CD4⁺ count is ∼ 1000 cells/μL; in AIDS it drops below 200.
6. Opportunistic infections. With the immune defence gone, organisms that the body normally easily controls (Mycobacterium tuberculosis, Pneumocystis jirovecii, Cryptococcus, Toxoplasma, cytomegalovirus, Candida) cause severe and recurrent infections, and certain cancers (Kaposi's sarcoma) develop. These are the clinical symptoms of AIDS.

HIV binds the CD4 receptor of helper T-cells/macrophages, reverse-transcribes its RNA into DNA, integrates into the host chromosome, replicates and buds out, killing the T_H cell. The progressive loss of T_H cells cripples the coordination of both humoral and cell-mediated immunity, leaving the patient open to opportunistic infections and cancers - the immunodeficiency we call AIDS.

Concept used. A normal cell grows and divides under the strict control of two systems: contact inhibition (cells stop dividing once they touch their neighbours) and cell-cycle checkpoints (the cell only divides when growth signals and DNA repair allow it). A cancerous cell (neoplastic cell) is one in which these controls have broken down: it divides repeatedly, ignores neighbour signals, refuses to die when damaged, and may break free of its original site.

1. Loss of contact inhibition. Normal cells stop dividing on touching neighbours, so a culture of normal cells forms a single layer (monolayer). Cancer cells ignore this contact signal and pile up on each other, forming multilayered, disorganised masses.
2. Uncontrolled, rapid division. Normal cells divide a limited number of times and only when needed (replacement, repair). Cancer cells divide continuously and rapidly, producing a mass of cells called a tumour.
3. Loss of differentiation. Normal cells differentiate into specialised cell types (e.g. liver cells, skin cells). Cancer cells lose their normal shape, size and function; they look immature (anaplastic) under the microscope.
4. Failure to die (apoptosis). Normal cells with damaged DNA trigger programmed death (apoptosis). Cancer cells escape apoptosis because regulatory genes such as p53 are mutated; damaged cells survive and accumulate.
5. Invasion and metastasis (in malignant tumours). Normal cells stay in their organ of origin. Malignant cancer cells break out of the primary site, invade surrounding tissues, enter blood and lymph, and seed distant organs - this is metastasis. Benign tumours, by contrast, stay encapsulated.
6. Angiogenesis. Malignant tumours secrete factors (VEGF) that recruit new blood vessels to feed themselves.
7. Genetic changes. Cancer cells carry mutations in proto-oncogenes (converted to oncogenes that drive growth) and in tumour-suppressor genes (e.g. p53, RB, which normally restrain growth). Normal cells have intact copies.
8. Other features. Cancer cells often have abnormal chromosome numbers (aneuploidy), high telomerase activity (so they do not senesce), altered metabolism (Warburg effect), and elevated tumour markers (CEA, PSA, AFP).

Cancer cells differ from normal cells in losing contact inhibition, dividing uncontrollably, losing differentiation, escaping apoptosis, sustaining their own blood supply, harbouring mutated oncogenes and tumour-suppressor genes, and (in malignant tumours) invading neighbouring tissues and metastasising to distant organs.

Concept used. Metastasis is the most dangerous property of malignant tumours. It is the process by which cancer cells of a primary (original) tumour break away, travel through the bloodstream and/or lymphatic system to distant parts of the body, settle there and grow into new (secondary) tumours. The word literally means a change of place. It is the single most important reason why cancer is hard to treat - once metastatic spread has happened, surgery alone cannot remove all the disease.

1. Detachment. Cancer cells in a malignant primary tumour lose cell-to-cell adhesion (down-regulated E-cadherin) and break out of their tissue of origin.
2. Invasion. They secrete proteolytic enzymes (matrix metalloproteinases) that digest the basement membrane and surrounding extracellular matrix, allowing the cells to push into nearby tissues.
3. Intravasation. The cells enter the lumen of blood capillaries or lymphatic vessels.
4. Circulation. Tumour cells travel as circulating tumour cells (CTCs) through blood or lymph. Most are destroyed by the immune system; a few survive.
5. Extravasation. A surviving cell adheres to the endothelium of a distant capillary, squeezes between endothelial cells, and enters the new tissue.
6. Colonisation. The cell multiplies at the new site, recruits new blood vessels (angiogenesis), and grows into a secondary (metastatic) tumour. Common sites of metastasis are the liver, lungs, bones and brain.

Metastasis is the spread of cancer cells from a malignant primary tumour, through the blood or lymphatic system, to distant organs, where they form new (secondary) tumours. It is the property that makes malignant cancer especially dangerous, because the disease is no longer confined to one site.

Concept used. Drug/alcohol abuse is the use of drugs (opioids, cannabinoids, cocaine, hallucinogens, tobacco) and alcohol for purposes other than medical, in amounts and frequencies that harm the user, the family and society. The harm acts at three levels: (i) the body of the user, (ii) the user's mind and behaviour, (iii) the user's family and society.

1. Immediate physical effects. Reckless behaviour, impaired judgement, accidents on the road, vandalism, violence. Heroin and alcohol overdose can cause respiratory depression and death. Loss of inhibition leads to unsafe sex, raising the risk of HIV and hepatitis B/C.
2. Long-term effects on the body.
   • Liver: chronic alcohol use causes fatty liver, alcoholic hepatitis and cirrhosis; long-term opioid use damages the liver too.
   • Heart and lungs: tobacco causes hypertension, atherosclerosis, coronary artery disease, chronic bronchitis, emphysema and lung cancer.
   • Nervous system: chronic abuse causes memory loss, dementia, peripheral neuropathy and Wernicke– Korsakoff syndrome (in alcoholics).
   • Reproductive system: reduced fertility, impotence in males, foetal alcohol syndrome in babies of alcoholic mothers (low birth weight, mental retardation, facial anomalies).
   • Infectious diseases: HIV, hepatitis B and C spread through shared needles among intravenous drug abusers.
3. Psychological effects. Dependence and addiction, depression, anxiety, paranoia, hallucinations (with cannabinoids), suicidal tendency, and a sharp drop in academic and work performance.
4. Withdrawal effects. Once dependent, stopping the drug suddenly produces severe nausea, sweating, tremors, muscle pain, hallucinations and seizures; this withdrawal can be life-threatening.
5. Tolerance and escalation. The body adapts so that the same dose stops giving the same `kick'; the user takes progressively larger doses, increasing the risk of overdose and toxicity.
6. Family and social effects. Disturbed family relationships, financial ruin, child neglect, domestic violence, school drop-out, and loss of employment. Generations of `addicts of addicts' if the cycle is not broken.
7. Crime and societal cost. To finance the habit, an addict may steal or sell stolen goods, sell illegal drugs, engage in prostitution. Drug trafficking and gang violence weaken the social fabric.
8. Use of performance-enhancing drugs in sport. Anabolic steroids cause acne, mood swings, depression, liver damage, kidney failure, masculinisation in females (facial hair, deepened voice, menstrual irregularities), feminisation in males (breast enlargement, shrunken testes), aggression and premature heart disease.

Drug and alcohol abuse harm the body (liver cirrhosis, heart disease, lung damage, brain damage, HIV/hepatitis from shared needles), the mind (addiction, depression, hallucinations, suicide), the family (financial ruin, neglect, violence) and society (crime, loss of productivity). They also raise the risk of overdose, foetal damage and premature death.

Concept used. Adolescence is a stage where the urge to belong is strong and the brain's risk-reward circuitry is still maturing. Peer pressure, the influence of friends and classmates, is one of the leading reasons that teenagers first try a drug or a drink. Studies and the NCERT text itself note that the company we keep is the single most important external factor in adolescent drug initiation. Hence the honest answer is yes, friends can strongly influence one to take alcohol or drugs, especially during early teenage.

1. How peer pressure operates. An adolescent wants to fit in, be accepted, be seen as `cool' or grown-up. When the peer group experiments with cigarettes, alcohol or drugs, the urge not to be left out, the fear of being teased, and the temptation of `just trying once' often win over good sense.
2. Curiosity and adventure-seeking. Teenagers seek novelty, take risks and like to challenge rules. Friends amplify this curiosity: `try it once and see, nothing will happen'.
3. Imitation of role-models. Older siblings, popular seniors and celebrities glamorised in films or social media are imitated. A friend who looks up to such a figure passes the influence on.

How to protect oneself.

1. Choose friends with care. Friendships built around sports, reading, music, dance, debate or community service give the same sense of belonging without the drug. Avoid groups where substance use is a routine `fun'.
2. Be assertive without being aggressive. A firm, polite `No, thanks' practised in advance is usually enough. One does not have to argue or apologise. True friends will accept the refusal.
3. Build self-esteem and self-identity. A teenager with strong self-respect, a sport or hobby and clear goals does not need a drug to feel adult. Parents, teachers and counsellors can help by acknowledging the student's achievements and giving responsibility.
4. Channel curiosity and energy into healthy outlets. Sports, music, art, NCC, NSS, scouts, debate, trekking, environmental clubs. These give a real `high' of achievement and friendship.
5. Talk to parents and teachers without fear. Open communication with adults at home and at school is a strong safety net. If something has already been tried, admitting it early is much safer than hiding it.
6. Seek help early. Counsellors, NACO helpline, de-addiction centres, family physicians. The earlier one seeks help, the easier the way back.
7. Learn the facts about drugs. Knowing what cigarettes, alcohol, cannabis and opioids actually do to the body and mind (the harmful effects listed in Q14) replaces glamour with realism.

Yes, friends - especially during adolescence - are a strong influence on drug or alcohol initiation. The way to protect oneself is to choose friends with care, learn to say a firm `No', build self-esteem and goals, channel energy into sports/hobbies, talk openly with parents and teachers, learn the facts about drugs, and seek counselling early if needed.

Concept used. Alcohol and drugs of abuse act on the reward pathway of the brain (the meso-limbic dopaminergic pathway, including the nucleus accumbens and the ventral tegmental area). They flood it with the neurotransmitter dopamine, far above the levels released by natural rewards like food, music or friendship. With repeated use the brain adapts to this artificial surge, producing two stubborn phenomena: tolerance (progressively larger doses are needed to feel the same kick) and dependence (the body and mind need the drug to feel normal). Together they make stopping extremely hard.

1. Tolerance. On repeated exposure, dopamine receptors in the reward pathway down-regulate (their number falls). The same dose now produces a smaller effect, so the user takes a larger dose to feel the previous `kick'. This escalation traps the user in an ever-rising spiral of use.
2. Physical dependence. The body alters its own biochemistry to function in the constant presence of the drug. When the drug is stopped, the altered biochemistry produces withdrawal symptoms - tremors, sweating, cramping, nausea, vomiting, seizures, severe anxiety, sometimes hallucinations and even death. The simplest way to make these symptoms go away is to take the drug again.
3. Psychological dependence (craving). The brain learns to associate the drug with relief from stress, boredom or sadness. The memory of pleasure becomes so strong that even years after the body has detoxed, a familiar place, friend or smell can trigger an intense craving and bring the user back to use (relapse).
4. Reward pathway rewiring. Natural rewards (food, music, friendship) stop feeling rewarding because the brain has reset its baseline to the drug. The user feels flat and joyless without the substance, deepening the dependence.
5. Social factors. Continued company with using friends, easy availability of the drug, family discord, unemployment, and stigma around seeking help all keep pulling the person back to the substance.
6. Triggers and relapse. Even after de-addiction, triggers such as stress, a known location, an old friend, or simply the time of day at which the user once consumed the drug can fire the craving. This is why relapse is common and why long-term support (counselling, family, de-addiction groups) is essential.

Because alcohol and drugs hijack the brain's reward pathway, the user develops tolerance (progressively larger doses needed for the same effect), physical dependence (severe withdrawal on stopping), psychological dependence (deep cravings) and a rewired reward circuit. These changes, combined with social pressures and easy availability, make it extremely hard to break the habit once it has been formed.

Concept used. A youngster's first contact with alcohol or drugs is rarely random. It is driven by a cluster of push factors (curiosity, peer pressure, family stress, social glamourisation) and pull factors (an immediate thrill of relaxation or excitement). Avoidance therefore needs an equally multi-pronged response.

What motivates youngsters.

1. Curiosity and thrill-seeking. Adolescents are biologically wired to seek novelty and adventure. `What if I try it once?' is a powerful pull.
2. Peer pressure. Friends who already use drugs may tease, dare or persuade. Wanting to fit in beats common sense (also covered in Q15).
3. Family stress. Frequent quarrels, lack of warmth at home, unrealistic academic expectations, divorce or neglect push the child to look for escape.
4. Failure to cope with academic and personal pressures. Heavy syllabus, competition, exam fear and peer comparison drive some adolescents to relaxants (alcohol, cannabinoids) or stimulants (cocaine, amphetamines).
5. Glamourisation in media. Films, web series, music videos and social media often depict drinking and drug use as `cool', adult or rebellious. Young viewers imitate their on-screen idols.
6. Easy availability. If alcohol, cigarettes and gateway drugs (cannabis) are easily available near schools and colleges, experimentation is far more likely.
7. Misinformation. `Everyone does it', `It is harmless', `I can stop whenever I want'. Such myths, spread by older peers and the internet, lower the barrier to first use.
8. Need for an identity and rebellion. Adolescence is a phase of identity formation. Some youngsters use drugs as a way to assert independence from parents and teachers.

How this can be avoided.

1. Early education about drugs. School syllabi should include factual information on what each drug does to the body and brain, replacing glamour with realism (the Q14 effects).
2. Strong, warm and communicative families. Parents who listen, who set reasonable expectations, who share meals and conversations with their children, who watch for early signs (changing friends, mood swings, falling grades, money missing) and who address them gently - these families have the lowest rates of drug abuse.
3. Teachers and counsellors as a safety net. Trained school counsellors, accessible without fear of punishment, can catch trouble early. Anonymous helplines (NACO, de-addiction centres) extend the net.
4. Avoid peer-pressure traps. Teach refusal skills, encourage choice of constructive peer groups, build self-esteem (see Q15).
5. Channel energy positively. Sports, music, dance, debate, NCC, NSS, scouts, art, social work. Real achievement is a far stronger natural high than any drug.
6. Address root stress. Mental-health counselling for anxiety, depression, exam fear or family discord treats the cause before the youngster reaches for a drug.
7. Regulate availability. Strict enforcement of laws on the sale of alcohol and tobacco to minors; control of narcotics; quick action on drug peddlers near schools and colleges.
8. Looking for danger signs. A sudden drop in grades, withdrawal from family, isolated lifestyle, unkempt appearance, weight loss, mood swings, missing money, changed peer group - any of these calls for a gentle adult conversation, not punishment.
9. Professional help on time. Once experimentation has begun, professional de-addiction (medical detox + counselling + family + group support) gives the best chance of recovery. The earlier the intervention, the better.
10. Role of media. Responsible portrayal in films and social media; warning labels; campaigns by celebrities; public-service messaging (NACO posters, NSS drives).

Curiosity, peer pressure, family stress, academic pressure, media glamourisation, easy availability and the need for an identity together motivate youngsters to try alcohol or drugs. Avoidance needs early factual education, warm families, accessible school counsellors, refusal skills, channelling of energy into sports and arts, mental-health support, strict regulation of availability, early detection of warning signs, prompt professional help and responsible media.